免疫功能低下患者的疫苗反应，重点关注细胞免疫。
Vaccine Response in the Immunocompromised Patient with Focus on Cellular Immunity.
作者信息
Bahrs Christina, Harrison Nicole
机构信息
Institute for Infectious Diseases and Infection Control, Jena University Hospital-Friedrich Schiller University, 07747 Jena, Germany.
Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, 1090 Vienna, Austria.
出版信息
Vaccines (Basel). 2022 May 31;10(6):882. doi: 10.3390/vaccines10060882.
Abstract
During the last few years, we have experienced a shift in how we evaluate the effectiveness of vaccines [...].
摘要
在过去几年里，我们在评估疫苗有效性的方式上经历了转变[...]。
相似文献
1
Vaccine Response in the Immunocompromised Patient with Focus on Cellular Immunity.免疫功能低下患者的疫苗反应，重点关注细胞免疫。
Vaccines (Basel). 2022 May 31;10(6):882. doi: 10.3390/vaccines10060882.
2
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.mRNA 新冠疫苗 2 剂接种对免疫功能低下成人因 COVID-19 住院的效果-9 个州，2021 年 1 月至 9 月。
MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1553-1559. doi: 10.15585/mmwr.mm7044e3.
3
COVID-19 vaccines: concerns beyond protective efficacy and safety.COVID-19 疫苗：除了保护效力和安全性之外的关注点。
Expert Rev Vaccines. 2021 Aug;20(8):1013-1025. doi: 10.1080/14760584.2021.1949293. Epub 2021 Jul 5.
4
Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children.儿童白喉-破伤风-无细胞百日咳疫苗的免疫持续时间和有效性。
JAMA Pediatr. 2019 Jun 1;173(6):588-594. doi: 10.1001/jamapediatrics.2019.0711.
5
Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.使用白细胞介素12增强猪对灭活疱疹病毒疫苗的细胞免疫反应。
Adv Vet Med. 1999;41:447-61. doi: 10.1016/s0065-3519(99)80034-2.
6
Seasonal influenza vaccines.季节性流感疫苗
Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3.
7
Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy.mRNA 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫在接受生物治疗的重症哮喘患者中的有效性和持久性。
Front Immunol. 2022 May 20;13:892277. doi: 10.3389/fimmu.2022.892277. eCollection 2022.
8
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.在免疫功能低下人群中使用佐剂重组带状疱疹疫苗的安全性概况：六项试验概述。
Drug Saf. 2021 Jul;44(7):811-823. doi: 10.1007/s40264-021-01076-w. Epub 2021 Jun 11.
9
Respiratory Syncytial Virus F Subunit Vaccine With AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice.呼吸道合胞病毒 F 亚单位疫苗联合 AS02 佐剂在 BALB/c 小鼠中诱导出均衡、强大的体液和细胞免疫应答。
Front Immunol. 2020 Sep 11;11:526965. doi: 10.3389/fimmu.2020.526965. eCollection 2020.
10
Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient.给予照顾免疫功能低下患者或与免疫功能低下患者同住的健康人减毒活疫苗相关的传播风险。
Infect Control Hosp Epidemiol. 2007 Jun;28(6):702-7. doi: 10.1086/517952. Epub 2007 Apr 20.
引用本文的文献
1
Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients.儿童心脏移植受者对SARS-CoV-2 mRNA疫苗的体液和细胞反应。
Heliyon. 2024 Dec 31;11(1):e41584. doi: 10.1016/j.heliyon.2024.e41584. eCollection 2025 Jan 15.
2
Prophylactic and therapeutic vaccine development: advancements and challenges.预防性和治疗性疫苗的研发：进展与挑战。
Mol Biomed. 2024 Nov 11;5(1):57. doi: 10.1186/s43556-024-00222-x.
3
COVID-19 Vaccination in Liver Cirrhosis: Safety and Immune and Clinical Responses.肝硬化患者的 COVID-19 疫苗接种：安全性、免疫及临床反应
GE Port J Gastroenterol. 2023 Nov 15;31(5):325-337. doi: 10.1159/000534740. eCollection 2024 Oct.
4
Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability.锌甘氨酰组氨酸金属有机配位聚合物作为一种具有体外货架稳定性的强效广谱流感疫苗平台。
Mol Pharm. 2023 Sep 4;20(9):4687-4697. doi: 10.1021/acs.molpharmaceut.3c00424. Epub 2023 Aug 21.
本文引用的文献
1
Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma.尽管多次接种异源严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗导致血清转化并在一名多发性骨髓瘤缓解期患者中建立了T细胞特异性记忆，但仍未诱导出受体结合域（RBD）特异性中和抗体
Vaccines (Basel). 2022 Feb 27;10(3):374. doi: 10.3390/vaccines10030374.
2
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.免疫功能低下患者接种新型冠状病毒 2 疫苗（BNT162b2 或 mRNA-1273）后的抗体反应：一项随机对照试验。
Clin Infect Dis. 2022 Aug 24;75(1):e585-e593. doi: 10.1093/cid/ciac169.
3
Cellular Immune Response after Vaccination in Patients with Cancer-Review on Past and Present Experiences.癌症患者接种疫苗后的细胞免疫反应——既往与当前经验综述
Vaccines (Basel). 2022 Jan 25;10(2):182. doi: 10.3390/vaccines10020182.
4
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.接种疫苗后癌症患者对 SARS-CoV-2 关切变异株的适应性免疫和中和抗体：CAPTURE 研究。
Nat Cancer. 2021 Dec;2(12):1305-1320. doi: 10.1038/s43018-021-00274-w. Epub 2021 Oct 27.
5
Establishment of an ELISpot Assay to Detect Cellular Immunity against in Vaccinated Kidney Transplant Recipients.建立一种酶联免疫斑点试验以检测接种疫苗的肾移植受者针对[具体内容缺失]的细胞免疫。
Vaccines (Basel). 2021 Dec 6;9(12):1438. doi: 10.3390/vaccines9121438.
6
Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients.造血干细胞移植受者针对严重急性呼吸综合征冠状病毒2的体液和细胞疫苗接种反应
Vaccines (Basel). 2021 Sep 25;9(10):1075. doi: 10.3390/vaccines9101075.
7
Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination.异基因造血干细胞移植后蜱传脑炎特异性淋巴细胞反应可预测疫苗接种后的体液免疫。
Vaccines (Basel). 2021 Aug 15;9(8):908. doi: 10.3390/vaccines9080908.
8
Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease.评估 BNT162b2 SARS-CoV-2 疫苗在医护人员、老年人和自身免疫性疾病免疫抑制患者中诱导的体液和细胞免疫。
Immunol Res. 2021 Dec;69(6):576-583. doi: 10.1007/s12026-021-09226-z. Epub 2021 Aug 21.
9
Impact of SARS-CoV-2 variants on the total CD4 and CD8 T cell reactivity in infected or vaccinated individuals.新冠病毒变异株对感染或接种个体中总 CD4 和 CD8 T 细胞反应性的影响。
Cell Rep Med. 2021 Jul 20;2(7):100355. doi: 10.1016/j.xcrm.2021.100355. Epub 2021 Jul 2.
10
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey.COVID-19 与干细胞移植：来自 EBMT 和 GETH 多中心前瞻性调查的结果。
Leukemia. 2021 Oct;35(10):2885-2894. doi: 10.1038/s41375-021-01302-5. Epub 2021 Jun 2.
Zotero 插件